ClinVar Miner

Submissions for variant NM_001163817.2(DHCR7):c.89G>C (p.Gly30Ala) (rs200334114)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Center of Genomic medicine, Geneva,University Hospital of Geneva RCV000449598 SCV000537708 pathogenic Smith-Lemli-Opitz syndrome 2016-09-14 criteria provided, single submitter clinical testing This heterozygous missense variant in the DHCR7 gene (autosomal recessive transmission) inherited from the mother was found to be present in combination with a second missense variant in the same gene (compound heterozygosity) in a young female patient with a severe form of ASD
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000449598 SCV000697858 likely pathogenic Smith-Lemli-Opitz syndrome 2016-09-09 criteria provided, single submitter clinical testing Variant summary: The DHCR7 c.89G>C (p.Gly30Ala) variant involves the alteration of a conserved nucleotide. 4/4 in silico tools predict a damaging outcome for this substitution (SNPs&GO not captured due to low reliability index). This variant was found in 6/121512 control chromosomes at a frequency of 0.0000494, which does not exceed the estimated maximal expected allele frequency of a pathogenic DHCR7 variant (0.0043301). It was reported in Smith-Lemi-Optitz Syndrome patients in compound heterozygosity with other pathogenic variants indicating causality. In one family, the variant was shown to co-segregate with the disease further supporting a deleterious outcome (Haas_JIMD_2007). To our knowledge, the variant was not assessed for its impact on the function of the DHCR7 protein by in vivo/vitro functional studies at the time of classification. Taken together, the variant shows evidence for pathogenicity however; in the absence of functional studies the pathogenicity of the variant cannot be established with absolute certainty, therefore it was classified as Likely pathogenic.
Counsyl RCV000449598 SCV000800521 uncertain significance Smith-Lemli-Opitz syndrome 2017-05-03 criteria provided, single submitter clinical testing
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics RCV000728279 SCV000855832 uncertain significance not provided 2017-07-25 criteria provided, single submitter clinical testing
Baylor Genetics RCV000449598 SCV001163343 likely pathogenic Smith-Lemli-Opitz syndrome criteria provided, single submitter clinical testing
CeGaT Praxis fuer Humangenetik Tuebingen RCV000728279 SCV001334465 pathogenic not provided 2020-02-01 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.